The proposed CRP will address problems in the area of high level waste immobilization and is of interest to countries that have either adopted the closed fuel cycle or could decide to do so in future.

Antibody-drug conjugates (ADCs) are promising biotherapeutic candidates that combine highly potent cytotoxic drugs with monoclonal antibodies (mAbs) for targeted drug delivery in the treatment of ...

The need for high-quality pharmaceutical development services has never been more pressing. Therefore, in a swift response to such demand, CD Formulation has recently rolled out its new Pharmaceutical ...

Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development. Pharmaceutical companies walk a tightrope in early drug development.

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...

Delve into the heart of vaccine development with our three-day virtual masterclass, guided by the esteemed Dr. Tudor Arvinte. This immersive course offers a unique blend of scientific rigor and ...

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle.

The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, ...